These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 16751794

  • 1. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y, Yao J, Meng Y, Kasai A, Hiramatsu N, Hayakawa K, Miida T, Takeda M, Okada M, Kitamura M.
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [Abstract] [Full Text] [Related]

  • 2. Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells.
    Yao J, Hiramatsu N, Zhu Y, Morioka T, Takeda M, Oite T, Kitamura M.
    J Am Soc Nephrol; 2005 Jan; 16(1):58-67. PubMed ID: 15537869
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
    Netherton SJ, Maurice DH.
    Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4.
    Cheng J, Thompson MA, Walker HJ, Gray CE, Diaz Encarnacion MM, Warner GM, Grande JP.
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F940-53. PubMed ID: 15280158
    [Abstract] [Full Text] [Related]

  • 5. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ, Liu H, Palmer D, Maurice DH.
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [Abstract] [Full Text] [Related]

  • 6. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
    Growcott EJ, Spink KG, Ren X, Afzal S, Banner KH, Wharton J.
    Respir Res; 2006 Jan 19; 7(1):9. PubMed ID: 16423283
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis.
    Yao J, Zhu Y, Sun W, Sawada N, Hiramatsu N, Takeda M, Kitamura M.
    Br J Pharmacol; 2007 Jun 19; 151(4):457-66. PubMed ID: 17435794
    [Abstract] [Full Text] [Related]

  • 10. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J, Grande JP.
    Exp Biol Med (Maywood); 2007 Jan 19; 232(1):38-51. PubMed ID: 17202584
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A.
    Clin Cancer Res; 2002 Feb 19; 8(2):589-95. PubMed ID: 11839681
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S, Dong H, Kim EJ, Weintraub L, Epstein PM, Lerner A.
    Biochem Pharmacol; 2005 Feb 01; 69(3):473-83. PubMed ID: 15652238
    [Abstract] [Full Text] [Related]

  • 16. PI3Kgamma is required for PDE4, not PDE3, activity in subcellular microdomains containing the sarcoplasmic reticular calcium ATPase in cardiomyocytes.
    Kerfant BG, Zhao D, Lorenzen-Schmidt I, Wilson LS, Cai S, Chen SR, Maurice DH, Backx PH.
    Circ Res; 2007 Aug 17; 101(4):400-8. PubMed ID: 17615371
    [Abstract] [Full Text] [Related]

  • 17. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.
    Cell Mol Biol Lett; 2005 Aug 17; 10(2):305-19. PubMed ID: 16010295
    [Abstract] [Full Text] [Related]

  • 18. Cross talk between NO and cyclic nucleotide phosphodiesterases in the modulation of signal transduction in blood vessel.
    Lugnier C, Keravis T, Eckly-Michel A.
    J Physiol Pharmacol; 1999 Dec 17; 50(4):639-52. PubMed ID: 10639014
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.